JP2005503126A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503126A5 JP2005503126A5 JP2002582984A JP2002582984A JP2005503126A5 JP 2005503126 A5 JP2005503126 A5 JP 2005503126A5 JP 2002582984 A JP2002582984 A JP 2002582984A JP 2002582984 A JP2002582984 A JP 2002582984A JP 2005503126 A5 JP2005503126 A5 JP 2005503126A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccinia virus
- strain
- health
- new york
- york city
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700618 Vaccinia virus Species 0.000 claims 20
- 230000002238 attenuated effect Effects 0.000 claims 4
- 238000004113 cell culture Methods 0.000 claims 3
- 230000029087 digestion Effects 0.000 claims 2
- 230000005847 immunogenicity Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 108091008146 restriction endonucleases Proteins 0.000 claims 2
- 231100000419 toxicity Toxicity 0.000 claims 2
- 230000001988 toxicity Effects 0.000 claims 2
- 206010011985 Decubitus ulcer Diseases 0.000 claims 1
- 208000004210 Pressure Ulcer Diseases 0.000 claims 1
- 241000700647 Variola virus Species 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 210000004748 cultured cell Anatomy 0.000 claims 1
- 230000012010 growth Effects 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000001902 propagating effect Effects 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/840,751 US6723325B1 (en) | 2001-04-23 | 2001-04-23 | Smallpox vaccine |
| PCT/US2002/012616 WO2002085411A1 (en) | 2001-04-23 | 2002-04-23 | Smallpox vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005503126A JP2005503126A (ja) | 2005-02-03 |
| JP2005503126A5 true JP2005503126A5 (https=) | 2006-01-12 |
| JP4397591B2 JP4397591B2 (ja) | 2010-01-13 |
Family
ID=25283120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002582984A Expired - Fee Related JP4397591B2 (ja) | 2001-04-23 | 2002-04-23 | 天然痘ワクチン |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6723325B1 (https=) |
| EP (1) | EP1381389B1 (https=) |
| JP (1) | JP4397591B2 (https=) |
| KR (1) | KR20040063083A (https=) |
| CN (1) | CN1527722A (https=) |
| AU (1) | AU2002258910B2 (https=) |
| BR (1) | BR0209145A (https=) |
| CA (1) | CA2444747C (https=) |
| CZ (1) | CZ305819B6 (https=) |
| EA (1) | EA007656B1 (https=) |
| ES (1) | ES2546612T3 (https=) |
| HU (1) | HU228401B1 (https=) |
| IL (2) | IL158549A0 (https=) |
| MA (1) | MA26270A1 (https=) |
| MX (1) | MXPA03009711A (https=) |
| NZ (1) | NZ529265A (https=) |
| PL (1) | PL212117B1 (https=) |
| WO (1) | WO2002085411A1 (https=) |
| ZA (1) | ZA200309084B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7645456B2 (en) * | 2001-04-23 | 2010-01-12 | Sanofi Pasteur Biologics Co. | Vaccinia virus strains |
| US6723325B1 (en) * | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
| US20090269365A1 (en) * | 2005-04-20 | 2009-10-29 | University Of Washington | Immunogenic vaccinia peptides and methods of using same |
| MX2009004862A (es) | 2006-11-07 | 2009-07-17 | Sanofi Pasteur Biologics Co | Estabilizacion de vacunas por liofilizacion. |
| KR100859345B1 (ko) * | 2006-12-12 | 2008-09-19 | 씨제이제일제당 (주) | 세포배양에 의해 두창 백신을 생산하는 방법 및 그에 의해생산된 두창 백신 |
| ES2733211T3 (es) * | 2011-04-15 | 2019-11-28 | Genelux Corp | Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas |
| RU2496149C1 (ru) * | 2012-06-19 | 2013-10-20 | Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") | Способ оценки противооспенной активности лечебно-профилактических препаратов |
| JP2019535311A (ja) | 2016-11-02 | 2019-12-12 | デイビッド エバンス， | 合成キメラポックスウイルス |
| EP3788142A4 (en) | 2018-05-02 | 2022-04-27 | Tonix Pharma Holdings Limited | SYNTHETIC CHIMERIC VACCINE VIRUS |
| US11505782B2 (en) | 2018-06-04 | 2022-11-22 | Calidi Biotherapeutics, Inc. | Cell-based vehicles for potentiation of viral therapy |
| CA3116192C (en) | 2018-11-06 | 2025-09-23 | Calidi Biotherapeutics (Nevada), Inc. | IMPROVED SYSTEMS FOR CELL-MEDIATED ONCOLYTIC VIRAL THERAPY |
| WO2025184411A1 (en) | 2024-02-27 | 2025-09-04 | Calidi Biotherapeutics (Nevada), Inc. | Serum-resistant eev viruses and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4315914A (en) * | 1980-04-04 | 1982-02-16 | Seiji Arakawa | Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof |
| JPS60202827A (ja) | 1984-03-28 | 1985-10-14 | Chibaken | 弱毒痘そうワクチン株 |
| US5614193A (en) * | 1991-11-14 | 1997-03-25 | The United States Of America As Represented By The Secretary Of The Army | Hantavirus vaccine |
| US5656465A (en) * | 1994-05-04 | 1997-08-12 | Therion Biologics Corporation | Methods of in vivo gene delivery |
| US6723325B1 (en) | 2001-04-23 | 2004-04-20 | Acambis, Inc. | Smallpox vaccine |
-
2001
- 2001-04-23 US US09/840,751 patent/US6723325B1/en not_active Expired - Lifetime
-
2002
- 2002-04-23 PL PL373958A patent/PL212117B1/pl unknown
- 2002-04-23 KR KR10-2003-7013866A patent/KR20040063083A/ko not_active Ceased
- 2002-04-23 HU HU0303878A patent/HU228401B1/hu unknown
- 2002-04-23 BR BR0209145-3A patent/BR0209145A/pt active Search and Examination
- 2002-04-23 CN CNA028126335A patent/CN1527722A/zh active Pending
- 2002-04-23 EP EP02728888.5A patent/EP1381389B1/en not_active Expired - Lifetime
- 2002-04-23 AU AU2002258910A patent/AU2002258910B2/en not_active Ceased
- 2002-04-23 EA EA200301151A patent/EA007656B1/ru not_active IP Right Cessation
- 2002-04-23 IL IL15854902A patent/IL158549A0/xx unknown
- 2002-04-23 JP JP2002582984A patent/JP4397591B2/ja not_active Expired - Fee Related
- 2002-04-23 ES ES02728888.5T patent/ES2546612T3/es not_active Expired - Lifetime
- 2002-04-23 WO PCT/US2002/012616 patent/WO2002085411A1/en not_active Ceased
- 2002-04-23 CZ CZ2003-3184A patent/CZ305819B6/cs not_active IP Right Cessation
- 2002-04-23 MX MXPA03009711A patent/MXPA03009711A/es active IP Right Grant
- 2002-04-23 NZ NZ529265A patent/NZ529265A/en not_active IP Right Cessation
- 2002-04-23 CA CA2444747A patent/CA2444747C/en not_active Expired - Lifetime
-
2003
- 2003-05-27 US US10/445,671 patent/US7115270B2/en not_active Expired - Lifetime
- 2003-10-22 IL IL158549A patent/IL158549A/en unknown
- 2003-11-17 MA MA27401A patent/MA26270A1/fr unknown
- 2003-11-21 ZA ZA2003/09084A patent/ZA200309084B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005503126A5 (https=) | ||
| Salvin et al. | Brief communication: tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity | |
| IL186993A (en) | Powerfully reduced microorganisms for the treatment of inflammation | |
| NO20026044L (no) | Behandling av humant papillomavirus | |
| AU4358801A (en) | Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences | |
| MX2009004223A (es) | Protocolo de inmunizacion contra los 4 serotipos del dengue. | |
| JP2005535328A5 (https=) | ||
| MY144492A (en) | Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types | |
| Cheung et al. | Detection of latent cytomegalovirus in murine salivary and prostate explant cultures and cells | |
| CA2115927A1 (en) | Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus | |
| JP2024506954A5 (https=) | ||
| JP2004535827A (ja) | ミコバクテリウム結核菌の菌力の減少およびｐｈｏＰ遺伝子の不活性化による結核菌に対する保護 | |
| Straus | Shingles: sorrows, salves, and solutions | |
| JP2009514840A5 (https=) | ||
| WO2003031599A3 (en) | Live attenuated salmonella strains for producing vaccines | |
| DE3579617D1 (de) | Lebender gereinigter impfstoff gegen die marek'sche krankheit. | |
| CA2457804A1 (en) | Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles | |
| MX2025012624A (es) | Oligonucléotidos para usar en la modulacion de respuestas inmunitarias contra la infección viral de la hepatitis b | |
| HUP0303878A2 (hu) | Himlő elleni vakcina | |
| BR0209251A (pt) | Vacina contra vìrus da febre aftosa | |
| ATE274579T1 (de) | Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus | |
| Banic | Prevention of rabies by vitamin C | |
| WO2017222295A1 (ko) | 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물 | |
| JPH09124496A (ja) | 感染防御剤 | |
| JP2005533116A5 (https=) |